Predictive Utility of Patient Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3
| dc.contributor.author | Gandara, D. R. | |
| dc.contributor.author | Gogishvili, M. | |
| dc.contributor.author | Sezer, A. | |
| dc.contributor.author | Makharadze, T. | |
| dc.contributor.author | Guemues, M. | |
| dc.contributor.author | McIntyre, D. A. | |
| dc.contributor.author | He, X. | |
| dc.contributor.author | Yan, E. | |
| dc.contributor.author | Gullo, G. | |
| dc.contributor.author | Rietschel, P. | |
| dc.contributor.author | Quek, R. G. | |
| dc.date.accessioned | 2024-04-24T08:26:34Z | |
| dc.date.available | 2024-04-24T08:26:34Z | |
| dc.date.issued | 2023 | |
| dc.identifier.eissn | 1556-1380 | en_US |
| dc.identifier.endpage | S117 | en_US |
| dc.identifier.issn | 1556-0864 | en_US |
| dc.identifier.issue | 11 | en_US |
| dc.identifier.startpage | S117 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11727/12037 | |
| dc.identifier.volume | 18 | en_US |
| dc.identifier.wos | 001098831600143 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Cemiplimab | en_US |
| dc.subject | Advanced non-small cell lung cancer | en_US |
| dc.subject | Patientreported outcomes | en_US |
| dc.title | Predictive Utility of Patient Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3 | en_US |
| dc.type | Conference Object | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: